Isoxazolines as inhibitors of fatty acid amide hydrolase
US8927551B2 · kind B2 · utility
0Cited by
48References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2010 |
| Grant date | Jan 6, 2015 |
| Priority date | — |
| Expiry date | Apr 24, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides isoxazoline FAAH inhibitors of the formula (I): The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient.The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.